The Embolization Coil Market is expected to grow at a CAGR of 6% to reach USD 538.3 million by 2028. In the dynamic and evolving embolization coil market, technological innovations play a pivotal role in catering to the requirements of key end-users, including hospitals, Ambulatory Surgery Centers (ASCs), clinics, and diagnostic centers. The global market for embolization coils has witnessed significant advancements, leading to the emergence of cutting-edge products such as 3D embolization coils, miniaturized coils, hydrocoils, and coils with integrated deployment mechanisms. These technological breakthroughs offer numerous benefits, including precise multi-planar deployment, accelerated thrombus formation, and flexible access to both smaller and larger blood vessels. Notably, 3D embolization coils, like Target 3D detachable coils from Stryker Corporation, are in a conformable 3D shape and are particularly effective in treating complex cases, such as wide-necked aneurysms or high-flow territories.
North America dominates the regional market because of The Embolization Coil Market represents a significant growth opportunity for businesses in the healthcare sector. These coils, used in interventional radiology procedures, offer an effective solution for treating various conditions, including uterine fibroids and arteriovenous malformations. With increasing prevalence of these conditions and rising demand for minimally invasive treatments, the market is poised for substantial expansion. Key players in this market include Boston Scientific, Merit Medical, and Cook Medical.
There are various factors that drive the Embolization Coil Market market which are as following: Aneurysms represent a significant health concern, particularly for those afflicted with aortic or cerebral varieties. These conditions arise due to weaknesses in the arterial walls of the heart, brain, knee, intestine, and spleen. Aneurysms may not exhibit discernible symptoms until rupture occurs, leading to potentially fatal hemorrhagic strokes (internal bleeding). Among the population, aortic and cerebral aneurysms are the most prevalent types. Brain aneurysms, characterized by bulging or ballooning of blood vessels, disproportionately affect individuals aged 35-40 years. In the United States, the annual brain aneurysm rupture rate stands at 9 cases per 100,000 population, with women being more susceptible than men (3:2 ratio).
Be the first one to get the industry updates. Request for a sample report
Embolization Coil Market Segmentation
The market witnesses several challenges, which are as follows Embolization coils, a commonly used interventional radiology tool for treating various vascular conditions, carry certain risks. Complications may arise due to coil migration or misplacement, incomplete coil retrieval, coil stretching, and limited coil length range, leading to non-target embolization. Potential complications include aneurysmal perforation and rupture, parent artery occlusion, cerebral embolism, neurological deficits such as stroke and death, and puncture site hematoma. Additionally, thromboembolic episodes, pain, vasospasm, infection, vascular thrombosis, clot formation, hemorrhage, and ischemia are other risks associated with embolization coil procedures. The invasive nature of the procedure carries risks such as damage to the blood vessel, bruising or bleeding at the puncture site, and infection.
Stay ahead of your competitors. Download the Free PDF report
Some of the key companies that have been profiled in the report include:
According to Technavio, the Embolization Coil Market is a significant segment within the expansive Global Healthcare Equipment Market. This market encompasses organizations involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, implants, accessories, and consumables. These products are utilized in the diagnosis, monitoring, and treatment of diverse disease areas. The Global Healthcare Equipment Market's size is determined by the consolidated revenue generated by manufacturers of diagnostic equipment and devices. The healthcare equipment sector is segmented into Devices, which incorporates advanced, differentiated, and clinically validated devices, including embolization coils. - The Embolization Coil Market is experiencing significant growth, fueled by the Increasing incidence of aneurysms. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
The Embolization Coil Market encompasses a range of medical devices used in minimally invasive procedures to treat various conditions, including arteriovenous malformations (AVMs) in the brain and other parts of the body. AVMs are abnormal tangles of veins and arteries that allow oxygenated blood to flow directly into venous system bypassing the capillaries, leading to symptoms such as vomiting, nausea, upper back pain, neck pain, headaches, and seizures. These symptoms occur due to the pressure on brain tissue and nerves caused by the malformation. Embolization coils are used to block the feeding arteries of the AVM, cutting off blood supply and causing the malformation to shrink. This procedure is also used to treat other conditions such as bronchial artery embolization for cardiovascular diseases like ischemic heart disease, peripheral vascular diseases, neuroendocrine tumors, aortic artery disorders, kidney cancer, liver cancer, and tumors. Surgical embolization is also used to treat blood related conditions like cardiac aneurysms and brain aneurysms. According to the World Health Organization, embolization coils are an effective alternative to surgery for many conditions, offering fewer complications and faster recovery times.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
